Merck & Co.
Visit at https://www.merck.com
Merck & Co.
Merck & Co. is a research-intensive biopharmaceutical company dedicated to developing innovative health solutions to prevent and treat diseases in humans and animals. It uses leading-edge science to improve lives worldwide.
Positive signals
Merck & Co., Inc. achieved an A- score for climate action from CDP in 2023, indicating strong performance in managing and reporting greenhouse gas emissions and climate-related risks.
Merck & Co., Inc. has been recognized for maintaining or exceeding its employee inclusion and engagement index scores through 2025, reflecting a sustained commitment to diversity and employee well-being.
Sustainalytics rates Merck & Co., Inc. as having a low ESG risk with an ESG Risk Rating of 15.5 in 2024, recognizing the company as a top performer in managing material ESG issues relevant to the pharmaceuticals industry.
Concerns
Failure to meet revenue expectations for Gardasil
HIGH
Source →Securities law violations related to revenue forecasts
HIGH
Source →According to Sustainalytics, Merck & Co., Inc. has faced a 'High' controversy rating within the last three years, indicating significant ESG-related incidents or risks that have impacted its overall ESG risk assessment.
HIGH
Source →
